Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 68786-66-3
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
68786-66-3 |
Appearance:: |
White To Brown Crystalline Powder |
Molecular Formula:: |
C14H9Cl3N2OS |
Molecular Weight:: |
359.65800 |
EINECS NO:: |
614-728-7 |
MDL NO:: |
MFCD00864519 |
CAS NO:: |
68786-66-3 |
Appearance:: |
White To Brown Crystalline Powder |
Molecular Formula:: |
C14H9Cl3N2OS |
Molecular Weight:: |
359.65800 |
EINECS NO:: |
614-728-7 |
MDL NO:: |
MFCD00864519 |
Product Description:
Product Name: Triclabendazole CAS NO: 68786-66-3
Synonyms:
6-CHLORO-5-(2,3-DICHLOROPHENOXY)-2-METHYLTHIO-BENZIMIDAZOLE;
5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-METHYLTHIO-1H-BENZIMIDAZOLE;
TRICLABENDAZOLE;
Chemical & Physical Properties:
Appearance: White to brown crystalline powder
Assay :≥99.0%
Density: 1.59 g/cm3
Boiling Point: 495.9℃ at 760 mmHg
Melting Point: 175 – 176℃
Flash Point: 253.7℃
Refractive Index: 1.724
Storage Condition: 0-6℃
Safety Information:
Safety Statements: S26; S36
HS Code: 2933990090
WGK Germany: 3
Risk Statements: R36/37/38
Hazard Code: Xn
Triclabendazole (commercial names: veterinary, liquid: Fasinex; human, tablets: Egaten, both manufactured by Novartis) is a member of the benzimidazole family of anthelmintics. The benzimidazole drugs share a common molecular structure, triclabendazole being the exception in having a chlorinated benzene ring but no carbamate group. Benzimidazoles such as triclabendazole are generally accepted to bind to beta-tubulin and prevent the polymerization of the microtubules of which they are part.
Triclabendazole was initially only developed as an oral route drug, and displays high efficacy against both immature and adult liver flukes.
Since late 1990s, triclabendazole became available as a generic drug, as patents expired in many countries. Many products were developed then. Among them, Trivantel 15, a 15% triclabendazole suspension, was launched by Agrovet Market Animal Health in the early 2000s. In 2009, the first triclabendazole injectable solution (combined with ivermectin) was developed and launched, also by Agrovet Market Animal Health. The product, Fasiject Plus, a triclabendazole 36% and ivermectin 0.6% solution, is designed to treat infections by Fasciola hepatica (both immature and adult liver flukes), roundworms and ectoparasites, as well.
It is on the World Health Organization's List of Essential Medicines, the most important medication needed in a basic health system.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.